These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 24246415)

  • 21. Outcome of tonsillectomy for recurrent IgA nephropathy after kidney transplantation.
    Koshino K; Ushigome H; Sakai K; Suzuki T; Nobori S; Okajima H; Masuzawa N; Yoshimura N
    Clin Transplant; 2013; 27 Suppl 26():22-8. PubMed ID: 24299232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrence of IgA nephropathy after kidney transplantation in steroid continuation versus early steroid-withdrawal regimens: a retrospective analysis of the UNOS/OPTN database.
    Leeaphorn N; Garg N; Khankin EV; Cardarelli F; Pavlakis M
    Transpl Int; 2018 Feb; 31(2):175-186. PubMed ID: 28926143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Galactose-Deficient IgA1 Derived From the Tonsils and Recurrence of IgA Nephropathy in Patients Who Underwent Kidney Transplantation.
    Kawabe M; Yamamoto I; Yamakawa T; Katsumata H; Isaka N; Katsuma A; Nakada Y; Kobayashi A; Koike K; Ueda H; Tanno Y; Koike Y; Miki J; Yamada H; Kimura T; Ohkido I; Tsuboi N; Yamamoto H; Kojima H; Yokoo T
    Front Immunol; 2020; 11():2068. PubMed ID: 33013875
    [No Abstract]   [Full Text] [Related]  

  • 24. Tonsillectomy delays progression of advanced IgA nephropathy to end-stage kidney disease.
    Komatsu H; Fujimoto S; Kikuchi M; Sato Y; Kitamura K
    Ren Fail; 2012; 34(4):448-53. PubMed ID: 22260382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
    Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
    Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria.
    Komatsu H; Sato Y; Miyamoto T; Tamura M; Nakata T; Tomo T; Nishino T; Miyazaki M; Fujimoto S
    Clin Exp Nephrol; 2016 Feb; 20(1):94-102. PubMed ID: 26123429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of IgA nephropathy: corticosteroids, tonsillectomy, and mycophenolate mofetil.
    Kawamura T
    Contrib Nephrol; 2007; 157():37-43. PubMed ID: 17495435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of recurrent disease and chronic allograft nephropathy on the long-term allograft outcome in patients with IgA nephropathy.
    Han SS; Huh W; Park SK; Ahn C; Han JS; Kim S; Kim YS
    Transpl Int; 2010 Feb; 23(2):169-75. PubMed ID: 19761553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tonsillectomy and steroid pulse therapy for recurrent IgA nephropathy in renal allograft.
    Tsuchiya T; Ito S; Yamaguchi Y; Moriyama Y; Ehara H; Deguchi T
    Clin Nephrol; 2010 Jan; 73(1):68-71. PubMed ID: 20040355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic evaluation of short-term outcome after early corticosteroid discontinuation in kidney transplantation.
    Miura M; Ogawa Y; Kubota KC; Harada H; Shimoda N; Seki T; Hirano T; Nonomura K
    Clin Transplant; 2009 Aug; 23 Suppl 20():10-6. PubMed ID: 19594589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical effectiveness of steroid pulse therapy combined with tonsillectomy in patients with immunoglobulin A nephropathy presenting glomerular haematuria and minimal proteinuria.
    Kawaguchi T; Ieiri N; Yamazaki S; Hayashino Y; Gillespie B; Miyazaki M; Taguma Y; Fukuhara S; Hotta O
    Nephrology (Carlton); 2010 Feb; 15(1):116-23. PubMed ID: 20377779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of oral steroids with tonsillectomy plus steroid pulse therapy in patients with IgA nephropathy.
    Hoshino Y; Moriyama T; Uchida K; Tsuchiya K; Nitta K
    Clin Exp Nephrol; 2017 Aug; 21(4):617-623. PubMed ID: 27549901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of kidney transplantation in patients with IgA nephropathy based on induction: A UNOS data analysis.
    Aydin-Ghormoz EA; Perlmutter J; Koizumi N; Ortiz J; Faddoul G
    Clin Transplant; 2024 Jan; 38(1):e15225. PubMed ID: 38127110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of tonsillectomy combined with steroid pulse therapy on immunoglobulin A nephropathy depending on histological classification: a multicenter study.
    Miyamoto T; Nishino T; Nakata T; Sato Y; Komatsu H; Uramatsu T; Ishimatsu N; Ishida K; Serino R; Otsuji Y; Miyazaki M; Tomo T; Tamura M; Fujimoto S
    Clin Exp Nephrol; 2016 Feb; 20(1):50-7. PubMed ID: 26055039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of immunosuppressive treatment on homocystein levels in patients after kidney transplantation during a 2 year observation period].
    Aksamit D; Janda K; Kuźniewski M; Krzanowski M; Ignacak E; Betkowska-Prokop A; Chowaniec E; Sułowicz W
    Przegl Lek; 2012; 69(11):1175-9. PubMed ID: 23646442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical remission and pathological progression after tonsillectomy in a renal transplant patient with recurrent IgA nephropathy.
    Sakai K; Saneshige M; Takasu J; Yanagisawa T; Aoki Y; Kawamura T; Mizuiri S; Aikawa A
    Clin Transplant; 2009 Aug; 23 Suppl 20():44-8. PubMed ID: 19594596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors.
    Gloor JM; Lager DJ; Moore SB; Pineda AA; Fidler ME; Larson TS; Grande JP; Schwab TR; Griffin MD; Prieto M; Nyberg SL; Velosa JA; Textor SC; Platt JL; Stegall MD
    Transplantation; 2003 Apr; 75(7):971-7. PubMed ID: 12698082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The low dose of rituximab in ABO-incompatible kidney transplantation without a splenectomy: a single-center experience.
    Shirakawa H; Ishida H; Shimizu T; Omoto K; Iida S; Toki D; Tanabe K
    Clin Transplant; 2011; 25(6):878-84. PubMed ID: 21175849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of kidney allograft in recipients with kidney disease of unknown etiology.
    Kim HJ; Kim H; Cho HS; Hwang JH; Jung IM; Ahn C; Ha J; Oh YK; Lim CS; Chae DW; Kim YS; Lee JP
    Clin Transplant; 2013; 27(6):866-74. PubMed ID: 24073884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
    Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
    Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.